Benzinga | Oct 29, 2021 06:35AM EDT

Immunogen Q3 EPS $(0.18), Inline, Sales $9.20M Miss $19.03M Estimate

Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a 38.46 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $9.20 million which missed the analyst consensus estimate of $19.03 million by 51.66 percent. This is a 49.42 percent decrease over sales of $18.19 million the same period last year.